Though implicated, it remains unclear if these antibodies contribute to disease, and an active question is whether the perturbation of LRP4 via autoantibodies leads to the denervation of muscle observed in ALS. The gene discussed is LRP4; the disease is amyotrophic lateral sclerosis.